Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025年2月1日 - 12:04AM
Edgar (US Regulatory)
EXHIBIT
A
SCHEDULE
13D/A
JOINT FILING AGREEMENT TERMINATION
Each
of the undersigned is a party to that certain Joint Filing Agreement, dated as of June 5, 2023 (the “Joint Filing Agreement”).
In accordance with the Joint Filing Agreement, each of the undersigned hereby agrees that the Joint Filing Agreement is terminated, effective
as of December 31, 2024.
IN
WITNESS WHEREOF, the parties have executed this Joint Filing Agreement Termination on January 24, 2025.
D&D
SOURCE OF LIFE HOLDING LTD.
| By: |
Era Regenerative Medicine Limited, a BVI company |
|
| Its: |
Sole Shareholder |
|
| |
|
|
| Signed: |
/s/ Qi Meng |
|
| By: |
Qi Meng |
|
| Its: |
Director |
|
| SHUFEN
DENG |
|
| |
|
| /s/
Shufen Deng |
|
Reeds (QX) (USOTC:REED)
過去 株価チャート
から 2 2025 まで 3 2025
Reeds (QX) (USOTC:REED)
過去 株価チャート
から 3 2024 まで 3 2025
Real-Time news about Reeds Inc (QX) (その他OTC): 0 recent articles
その他のReeds Inc (QX)ニュース記事
